Cross-border M&A, deal structuring, due diligence, and corporate finance strategies for mid-market and enterprise transactions.
Three landmark deals — KKR’s acquisition of EDF Power Solutions, ON Semiconductor’s $7bn Synaptics deal, and Merck KGaA’s $11.3bn Bio-Techne purchase — signal a structural acceleration in cross-border M&A across energy, AI hardware, and life sciences. Mid-market decision-makers must reassess valuation benchmarks, regulatory exposure, and exit readiness now.
The £3.1bn Mitie-OCS takeover is the latest signal in a broad wave of European M&A consolidation spanning outsourcing, energy, and infrastructure. CFOs and M&A Directors must act with strategic clarity as private equity-backed deals and cross-border transactions redefine sector dynamics in 2025.
Merck KGaA’s $11.3B acquisition of Bio-Techne and ON Semiconductor’s $7B purchase of Synaptics headline a pivotal 48-hour surge in cross-border M&A, signaling durable investor conviction in life sciences and physical AI. Regulatory headwinds in semiconductor deals and PE activity in energy infrastructure complete a picture of a market in structural transition.
A cluster of cross-border transactions totalling over $140 billion — from GameStop’s unsolicited $56B eBay bid to Stripe’s joint $53B PayPal offer — signals a structural shift in global M&A activity. For CFOs, General Counsel, and M&A Directors, execution discipline and regulatory preparedness have never been more critical.
A week of landmark transactions — including GameStop’s $56B unsolicited eBay bid and Merck KGaA’s $11.3B Bio-Techne acquisition — reveals the structural forces reshaping global M&A strategy. CFOs and boards must reassess deal readiness, regulatory exposure, and AI-driven valuation dynamics.
Merck KGaA’s $11.3 billion acquisition of Bio-Techne headlines a week of transformative M&A activity spanning life sciences, semiconductors, energy, and defense. LLS examines what these cross-border deals signal for corporate finance strategy in 2025.
Three landmark deals totalling over $33 billion — Merck KGaA’s acquisition of Bio-Techne, ON Semi’s purchase of Synaptics, and Uber’s bid for Delivery Hero — signal a decisive acceleration in cross-border M&A activity across life sciences, AI hardware, and logistics. Decision-makers must navigate elevated regulatory scrutiny and integration complexity to capture strategic value.
A single week of M&A announcements exceeding $90 billion — led by Merck KGaA, Uber, and ON Semiconductor — reveals where strategic capital is concentrating in 2025. Decision-makers must act on the regulatory, valuation, and integration implications now.
Merck KGaA’s $11.3B acquisition of Bio-Techne and ON Semiconductor’s $7B Synaptics deal mark a defining moment in cross-border M&A, reflecting structural consolidation in life sciences and AI hardware. Decision-makers must act now to build the regulatory, financial, and integration capabilities required to compete in this environment.
A wave of cross-border M&A transactions totaling over $25 billion — led by Merck KGaA’s $11.3B acquisition of Bio-Techne — signals a strategic realignment across life sciences, energy, and AI sectors in 2025. Decision-makers must act with speed while navigating an increasingly complex regulatory and integration landscape.